Columbine Speech Therapy is a
Speech-language Pathologist based in Dillon, Colorado. Columbine Speech Therapy is licensed to practice in Colorado (license number 108355) and their current practice location is
126 Snowberry Way, Dillon, Colorado. It can be reached at their office (for appointments etc.) via phone at
(970) 389-6598.
NPI number for Columbine Speech Therapy is 1376096446 and their current mailing address is 126 Snowberry Way, Dillon, Colorado. Columbine Speech Therapy
does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1376096446.
Healthcare Provider's Profile
Full Name | Columbine Speech Therapy |
---|
Type | Facility |
---|
Speciality | Speech-language Pathologist |
---|
Location | 126 Snowberry Way, Dillon, Colorado |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
NPI Data:
- NPI Number: 1376096446
- Provider Enumeration Date: 07/25/2016
- Last Update Date: 07/25/2016
Medical Identifiers
Medical identifiers for Columbine Speech Therapy such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1376096446 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
235Z00000X | Speech-language Pathologist | 108355 (Colorado) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Columbine Speech Therapy is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Columbine Speech Therapy 126 Snowberry Way, Dillon, CO 80435-8353 Ph: (970) 389-6598 | Columbine Speech Therapy 126 Snowberry Way, Dillon, CO 80435-8353 Ph: (970) 389-6598 |
Reviews and Comments